| Evaluation and comparison of bioinformatic tools for the enrichment analysis of metabolomics data A Marco-Ramell, M Palau-Rodriguez, A Alay, S Tulipani, M Urpi-Sarda, ... BMC bioinformatics 19, 1-11, 2018 | 133 | 2018 |
| Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer D Caballero-Díaz, E Bertran, I Peñuelas-Haro, J Moreno-Càceres, ... Journal of Hepatology 72 (1), 125-134, 2020 | 32 | 2020 |
| Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification A Alay, D Cordero, S Hijazo-Pechero, E Aliagas, A Lopez-Doriga, R Marín, ... Journal for immunotherapy of cancer 9 (2), 2021 | 15 | 2021 |
| Gene expression profiling as a potential tool for precision oncology in non-small cell lung cancer S Hijazo-Pechero, A Alay, R Marín, N Vilariño, C Muñoz-Pinedo, ... Cancers 13 (19), 4734, 2021 | 13 | 2021 |
| Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma E Aliagas, A Alay, M Martínez-Iniesta, M Hernández-Madrigal, D Cordero, ... British Journal of Cancer 125 (10), 1365-1376, 2021 | 12 | 2021 |
| The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression I Peñuelas‐Haro, R Espinosa‐Sotelo, E Crosas‐Molist, ... Hepatology 78 (2), 416-433, 2023 | 10 | 2023 |
| Breast cancer dormancy is associated with a 4NG1 state and not senescence C Prunier, A Alay, M van Dijk, KL Ammerlaan, S van Gelderen, DL Marvin, ... NPJ Breast Cancer 7 (1), 140, 2021 | 10 | 2021 |
| MA23. 02 CDK4/6 inhibitors show antitumor effects in preclinical models of malignant pleural mesothelioma E Aliagas, M Martinez-Iniesta, M Hernandez, A Alay, D Cordero, X Solé, ... Journal of Thoracic Oncology 14 (10), S343, 2019 | 6 | 2019 |
| Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma R Espinosa-Sotelo, NP Fusté, I Peñuelas-Haro, A Alay, G Pons, ... Redox Biology 65, 102818, 2023 | 2 | 2023 |
| Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications S Hijazo‐Pechero, A Alay, D Cordero, R Marín, N Vilariño, R Palmero, ... Molecular Oncology 18 (2), 453-470, 2024 | | 2024 |
| Germline and somatic testing in a cohort of malignant mesothelioma (G-MESO) M Gausachs, C Castillo, A Teule, J Brenes, M Jove, R Palmero, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 560-560, 2024 | | 2024 |
| Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre M Mosteiro, D Azuara, S Villatoro, A Alay, M Gausachs, M Varela, ... ESMO open 8 (6), 102197, 2023 | | 2023 |
| Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities S Hijazo‐Pechero, A Alay, D Cordero, R Marín, N Vilariño, R Palmero, ... Clinical and Translational Medicine 13 (9), 2023 | | 2023 |
| 136P Germline testing in a cohort of malignant mesothelioma (G-MESO) E Nadal, M Gausachs, C Castillo, A Teulé, J Brenes, M Jové, R Palmero, ... Journal of Thoracic Oncology 18 (4), S117, 2023 | | 2023 |
| The hepatocyte Epidermal Growth Factor Receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche E Gonzalez-Sanchez, J Vaquero, D Caballero-Diaz, J Grzelak, NP Fuste, ... bioRxiv, 2023.11. 03.565317, 2023 | | 2023 |
| EP16. 03-027 Routine Molecular Testing Using the TSO500+ NGS Panel in a Cohort of Patients with NSCLC MM Lamas, D Azuara, R Palmero, M Varela, D Cordero, N Baixeras, ... Journal of Thoracic Oncology 17 (9), S600-S601, 2022 | | 2022 |
| P2. 14-04 Re-Definition of Lung Adenocarcinoma Transcriptional Subtypes Using Integrative Bioinformatics Approaches S Hijazo-Pechero, A Alay, D Cordero, R Marín, A Villanueva, R Palmero, ... Journal of Thoracic Oncology 17 (9), S158, 2022 | | 2022 |
| Immune-based classification of pleural malignant mesothelioma by using integrative transcriptome analysis E Nadal, A Alay, D Cordero, E Aliagas, J Ruffinelli, R Palmero, R Ramos, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| Integrative Transcriptome Analysis of Malignant Pleural Mesothelioma Reveals a Clinically-Relevant Immune-Based Classification A Alay, D Cordero, E Aliagas, S Hijazo-Pechero, V Moreno, ... JOURNAL OF THORACIC ONCOLOGY 14 (10), S298-S298, 2019 | | 2019 |
| MA12. 07 Integrative Transcriptome Analysis of Malignant Pleural Mesothelioma Reveals a Clinically-Relevant Immune-Based Classification A Alay, D Cordero, E Aliagas, S Hijazo-Pechero, V Moreno, RP Sánchez, ... Journal of Thoracic Oncology 14 (10), S298, 2019 | | 2019 |
